Sally Francis, Panacea’s QPPV, and Anne Dougherty, Quality Manager, attended PIPA’s 7th Annual Conference and Exhibition, held in July. The conference covered a lot of ground, with discussion and debate around key topics such as signal detection, risk management plans, copyright licensing, data protection, and the provision of medical information. The two-day conference programme included a range of presentations and workshops from expert speakers, with around 130 delegates attending the event from a wide range…
The field of post-marketing pharmacovigilance is very different in Europe, largely due to the legislation, and we had the option of bringing someone into the business to set-up our own internal post-marketing service, or working together with a company who could provide pharmacovigilance support in the post-marketing phase. We decided to go with Panacea Pharma Projects because we felt that they really understood our needs and requirements. — European Generics Company
